Leadership Overview
Tolmar has 6 executives leading key functions including strategy, finance, medical affairs, operations, legal, and commercialization.
Driven by a commitment to patient well-being, Tolmar focuses on the integrated development, manufacturing, and commercialization of specialty pharmaceuticals, impacting multiple therapeutic areas with a strong emphasis on Urology.
Driven by a commitment to patient well-being, Tolmar focuses on the integrated development, manufacturing, and commercialization of specialty pharmaceuticals, impacting multiple therapeutic areas with a strong emphasis on Urology.
Leadership Roles at Tolmar
Anil D'Souza - Chief Executive Officer
Anil D'Souza, the Chief Executive Officer at Tolmar, directs the company's overarching strategy and operational execution. D'Souza guides the integrated development, manufacturing, and commercialization of specialty pharmaceuticals, with a particular focus on the Urology therapeutic area. Overseeing global operations from Northern Colorado, the Chief Executive Officer ensures alignment with market demands and therapeutic advancements. This leadership role involves driving innovation across the product lifecycle, from initial research to market launch. By fostering cross-functional collaboration, Anil D'Souza ensures the company's mission to deliver high-quality pharmaceutical solutions is consistently met. The Chief Executive Officer's vision shapes Tolmar's expansion and impact within the pharmaceutical landscape.
Jeff Lederman - Chief Financial Officer
Jeff Lederman, the Chief Financial Officer at Tolmar, manages all financial operations and strategic fiscal planning. Lederman oversees budgeting, forecasting, and financial reporting, ensuring robust fiscal health across the organization. Directing financial strategy from the North America commercial headquarters in Buffalo Grove, Illinois, the Chief Financial Officer supports the company's growth objectives. This critical role involves managing capital allocation, investor relations, and risk management to safeguard company assets. By optimizing financial processes, Jeff Lederman enables the efficient development and commercialization of specialty pharmaceuticals. The Chief Financial Officer's expertise is vital for sustaining Tolmar's market position and driving long-term financial stability.
Shawn Silvestri - President & Chief Operating Officer
Shawn Silvestri, the President & Chief Operating Officer at Tolmar, executes the company's operational blueprint and drives day-to-day business functions. Silvestri manages the integrated manufacturing and product development facilities based in Northern Colorado, ensuring operational excellence and scalability. Overseeing the entire operational spectrum, the President & Chief Operating Officer ensures efficient production and timely delivery of specialty pharmaceuticals. This leadership position involves optimizing supply chain logistics and enhancing manufacturing processes to meet stringent quality standards. By driving operational efficiency, Shawn Silvestri supports Tolmar's mission to commercialize innovative treatments. The President & Chief Operating Officer's focus on operational performance is fundamental to the company's integrated model.
Steve Griffin - President, North America
Steve Griffin, the President, North America at Tolmar, spearheads commercial strategy and market penetration within the region. Griffin directs sales, marketing, and distribution efforts from the North America commercial headquarters in Buffalo Grove, Illinois, driving revenue growth for specialty pharmaceuticals. Overseeing the North American market, the President, North America ensures alignment with global commercial objectives and therapeutic area focuses, particularly Urology. This leadership role involves building strong relationships with healthcare providers and key stakeholders to expand market access. By optimizing commercial execution, Steve Griffin enhances Tolmar's presence and impact across the continent. The President, North America's leadership is key to achieving regional business goals.
Anjan Chatterjee - Chief Medical Officer & Chief Marketing Officer
Anjan Chatterjee, the Chief Medical Officer & Chief Marketing Officer at Tolmar, leads both clinical strategy and market engagement. Chatterjee oversees the medical affairs division, ensuring the scientific integrity and therapeutic efficacy of pharmaceutical products, particularly in Urology. Simultaneously, the Chief Medical Officer & Chief Marketing Officer directs commercialization efforts, shaping market positioning and go-to-market strategies. Operating from Northern Colorado, this dual role ensures seamless integration between product development and market needs. By bridging clinical insights with commercial execution, Anjan Chatterjee drives product adoption and patient access. The Chief Medical Officer & Chief Marketing Officer's comprehensive oversight is essential for Tolmar's success in specialty pharmaceuticals.
Michael Elm - Chief Legal Officer
Michael Elm, the Chief Legal Officer at Tolmar, provides strategic legal counsel and ensures regulatory compliance across all operations. Elm oversees the legal framework governing product development, manufacturing, and commercialization, mitigating risks and protecting company interests. Directing legal affairs from Northern Colorado, the Chief Legal Officer ensures adherence to pharmaceutical industry regulations and corporate governance standards. This vital role involves managing intellectual property, contracts, and litigation to support Tolmar's business objectives. By navigating complex legal landscapes, Michael Elm safeguards the company's operations and facilitates its expansion in specialty pharmaceuticals. The Chief Legal Officer's expertise is crucial for maintaining Tolmar's integrity and compliance.
Explore Leadership Teams in Manufacturing
Founded in 1947 and headquartered in Mumbai, Indoco Remedies Limited is a fully integrated, research-oriented pharma company. Indoco specializes in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
Company Leadership
AR
AK
BD
Founded in 1850 and headquartered in Johannesburg, South Africa, Aspen Pharmacare Holdings Limited is a global specialty and branded pharmaceutical company headquartered in Durban, South Africa. Operating across Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia, Aspen focuses on sterile injectables (including anaesthetics, anticoagulants, antithrombotics, analgesics, and hormone replacement therapies), over-the-counter medicines, and prescription products for conditions such as hypothyroidism, autoimmune disease, pain, gout, and inflammatory disorders. The company also manufactures active pharmaceutical ingredients and finished dose forms, including steriles, oral solids, liquids, semi-solids, biologicals, and heparins, supplying both its own brands and third-party customers worldwide.
Company Leadership
TS
RM
SC
UCB is a global biopharmaceutical company headquartered in Brussels, Belgium, founded in 1928. The company specializes in the discovery, development, and commercialization of innovative medicines for people living with severe neurological and autoimmune conditions. UCB's core therapeutic focus spans neurology — including epilepsy and Parkinson's disease — and immunology, encompassing conditions such as rheumatoid arthritis, Crohn's disease, psoriasis, and axial spondyloarthritis. Its marketed product portfolio includes Cimzia, Vimpat, Keppra, Briviact, Neupro, Bimzelx, Evenity, and Fintepla, among others. The company operates in more than 40 countries, with its U.S. headquarters located in Smyrna, Georgia, and additional sites across the United States supporting clinical development, research, and policy functions. UCB integrates patient and caregiver insights directly into its research and development process, combining scientific innovation with a commitment to health equity and sustainable value creation.
Company Leadership MD
DX
CD
SO
Founded in 1891, Adcock Ingram is a pharmaceutical manufacturer headquartered in Gauteng, South Africa. Adcock Ingram manufactures, markets and distributes a range of healthcare products.
Company Leadership AH
WR
FC
GH